866P ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)

Bibliographic Details
Published in:Annals of Oncology
Main Authors: Forster, M., Mendes, R., Guerrero Urbano, T., Evans, M., Lei, M., Spanswick, V., Miles, E., Simões, R., Wheeler, G., Forsyth, S., White, L.
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier BV 2021
Subjects:
Online Access:http://dx.doi.org/10.1016/j.annonc.2021.08.1276
https://api.elsevier.com/content/article/PII:S0923753421035055?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753421035055?httpAccept=text/plain
Description
Description not available.